Medicago to develop two Ebola antibodies under PHAC contract

Tuesday, Nov 3, 2015 @ 1:10pm by BioPrepWatch Reports

Medicago, Inc., announced last week that they have signed a contract with the Public Health Agency of Canada (PHAC) to develop two antibodies to fight against the Sudan strain of the Ebola virus.
Read More »

Senators introduce bipartisan pandemic protection legislation

Monday, Sep 21, 2015 @ 3:16pm by BioPrepWatch Reports

Bill encourages further measures against biological threats.
Read More »

N.C. governor increases privacy protection of first responders

Friday, Aug 21, 2015 @ 11:05am by BioPrepWatch Reports

North Carolina Gov. Pat McCrory announced on Wednesday that he has enacted a law that will prevent the disclosure of the personal information of first-response personnel and government-issued cell phone numbers.
Read More »

Chemring Detection Systems announces new detector for chemicals, explosives and narcotics

Monday, Jun 22, 2015 @ 5:23pm by BioPrepWatch Reports

Chemring Detection Systems (CDS) has launched the PGR-1064, a handheld device capable of chemical, explosive and narcotic identification, the company announced on Monday.
Read More »

AirBoss acquires Immediate Response Technologies

Thursday, Jun 18, 2015 @ 8:25pm by BioPrepWatch Reports

Air Boss of America Corp. and Immediate Response Technologies LLC. (IRT) have entered into an acquisition agreement, AirBoss announced Wednesday.
Read More »

Study finds bubonic plague host-cell tenet faulty

Friday, Feb 13, 2015 @ 5:16pm by BioPrepWatch Reports

A recent study at the University of North Carolina School of Medicine has shown that the bacteria that cause the bubonic plague do not need to hijack a host cell to travel to the lymph nodes and multiply.
Read More »

Cempra receives $16M from BARDA for drug study

Friday, Nov 21, 2014 @ 1:55pm by BioPrepWatch Reports

Cempra Inc. announced on Thursday that is will receive an additional $16 million from the Biomedical Advanced Research and Development Authority (BARDA) for two more clinical studies of its drug solithromycin on pediatric patients with bacterial infections.
Read More »